Informing MS patients on treatment options: a consensus on the process of consent taking

In the last years, change in multiple sclerosis (MS) therapeutic scenario has highlighted the need for an improved doctor-patient communication in advance of treatment initiation in order to allow patient’s empowerment in the decision-making process. Aims The aims of our project were to review the s...

Full description

Saved in:

Bibliographic Details
Published in:	Neurological sciences Vol. 41; no. 8; pp. 2249 - 2253
Main Authors:	Tortorella, C., Solaro, C., Annovazzi, P., Boffa, L., Buscarinu, M. C., Buttari, F., Calabrese, M., Cavalla, P., Cocco, E., Cordioli, C., De Luca, G., Di Filippo, M., Fantozzi, R., Ferraro, D., Gajofatto, A., Gallo, A., Lanzillo, R., Laroni, A., Fermo, S. Lo, Malucchi, S., Maniscalco, G. T., Moccia, M., Nociti, V., Paolicelli, D., Pesci, I., Prosperini, L., Ragonese, P., Tomassini, V., Clerici, V. L. A. Torri, Rodegher, M., Gherardi, M., Gasperini, C.
Format:	Journal Article
Language:	English
Published:	Cham Springer International Publishing 01-08-2020 Springer Nature B.V
Subjects:	Advisors Brief Communication Clinical medicine Communication Consensus Decision making Disease Empowerment Humans Informed Consent Italy Medical prognosis Medicine Medicine & Public Health Multiple sclerosis Multiple Sclerosis - therapy Neurology Neuroradiology Neurosciences Neurosurgery Patients Physician-Patient Relations Psychiatry Italy Informed consent Multiple sclerosis Disease modifying treatment
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	In the last years, change in multiple sclerosis (MS) therapeutic scenario has highlighted the need for an improved doctor-patient communication in advance of treatment initiation in order to allow patient’s empowerment in the decision-making process. Aims The aims of our project were to review the strategies used by Italian MS specialists to inform patients about treatment options and to design a multicentre shared document that homogenizes the information about disease-modifying treatment (DMTs) and the procedure of taking informed consent in clinical practice. Results The new resource, obtained by consensus among 31 neurologists from 27 MS Centres in Italy with the supervision of a medico-legal advisor, received the aegis of Italian Neurological Society (SIN) and constitutes a step toward a standardized decision process around DMTs in MS.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1590-1874 1590-3478
DOI:	10.1007/s10072-020-04339-z